These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8906437)

  • 1. A checkerboard method to evaluate interactions between drugs.
    Michaud JP
    Hum Exp Toxicol; 1996 Oct; 15(10):859-60. PubMed ID: 8906437
    [No Abstract]   [Full Text] [Related]  

  • 2. A system of models for the action of drugs applied singly or jointly to biological organisms.
    Ashford JR; Cobby JM
    Biometrics; 1974 Mar; 30(1):11-31. PubMed ID: 4813377
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between drugs using three-dimensional isobolographic interpretation.
    Gershwin ME; Smith NT
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):154-61. PubMed ID: 4197879
    [No Abstract]   [Full Text] [Related]  

  • 4. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.
    Chou TC
    Pharmacol Rev; 2006 Sep; 58(3):621-81. PubMed ID: 16968952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions and the evolution of antibiotic resistance.
    Yeh PJ; Hegreness MJ; Aiden AP; Kishony R
    Nat Rev Microbiol; 2009 Jun; 7(6):460-6. PubMed ID: 19444248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical analysis of isoboles.
    Scaf AH
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):138-65. PubMed ID: 4276929
    [No Abstract]   [Full Text] [Related]  

  • 7. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
    Meletiadis J; te Dorsthorst DT; Verweij PE
    Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some potential interactions between prescribed drugs and over-the-counter drug products.
    Turner JN
    Calif Med; 1972 Sep; 117(3):13-21. PubMed ID: 5070693
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological basis of the concepts of synergism, antagonism and potentiation].
    Tillement JP
    Minerva Anestesiol; 1972 Feb; 38(2):58-66. PubMed ID: 4670303
    [No Abstract]   [Full Text] [Related]  

  • 10. Dose-response analysis of combination preparations.
    Unkelbach HD; Wolf T
    Stat Med; 1985; 4(1):77-85. PubMed ID: 3992075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of combined drug action].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1992 Jul; 23(3):248-53. PubMed ID: 1299964
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interactions between antibacterial drugs].
    Witkowska M; Prandota J
    Postepy Hig Med Dosw; 1976; 30(5):561-77. PubMed ID: 1019051
    [No Abstract]   [Full Text] [Related]  

  • 13. [The inter-action between drugs].
    Wislicki L
    Harefuah; 1971 Oct; 81(7):344-6. PubMed ID: 5141717
    [No Abstract]   [Full Text] [Related]  

  • 14. Concepts of synergism and antagonism.
    Merlin JL
    Anticancer Res; 1994; 14(6A):2315-9. PubMed ID: 7825965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism, antagonism, or additivity of dietary supplements: application of theory to case studies.
    Borgert CJ; Borgert SA; Findley KC
    Thromb Res; 2005; 117(1-2):123-32; discussion 145-51. PubMed ID: 16023178
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the effect of drugs due to reciprocal interference with their protein binding and catabolism].
    Remmer H
    Dtsch Med Wochenschr; 1974 Mar; 99(9):413-9. PubMed ID: 4857236
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interactions of dental drugs and their causes].
    Estler CJ
    Zahnarztl Mitt; 1979 Jun; 69(12):738-45. PubMed ID: 37666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Principle factors liable to modify the activity of curare-like agents].
    Viars P
    Anesth Analg (Paris); 1973; 30(5):877-93. PubMed ID: 4276410
    [No Abstract]   [Full Text] [Related]  

  • 19. Models of agonist-antagonist interaction [proceedings].
    Vere DW
    Br J Pharmacol; 1976 Jul; 57(3):470P. PubMed ID: 974360
    [No Abstract]   [Full Text] [Related]  

  • 20. A generalized response surface model with varying relative potency for assessing drug interaction.
    Kong M; Lee JJ
    Biometrics; 2006 Dec; 62(4):986-95. PubMed ID: 17156272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.